By increasing muscle loss and decreasing cardiorespiratory fitness, weight-loss drugs can negatively affect mortality risk, ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

A breakthrough has been made in weight-loss drugs after scientists discovered a new medication – known as TDP – that works ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

Stopping anti-obesity medications leads to significant weight regain, starting as early as eight weeks and stabilizing by six ...

Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...

A study finds that adjunctive use of GLP-1 receptor agonists before and after undergoing bariatric surgery produces greater ...